News
Explore the latest changes in drug pricing as Trump aims to revamp Medicare negotiations for prescription drugs.
The immune system must be able to quickly attack invaders like viruses, while also ignoring harmless stimuli, or allergies can result. Immune cells are known to ignore or "tolerate" molecules found on ...
TD Cowen analyst Steve Scala maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The company’s ...
Music is an important part of many religious ceremonies by lifting spirits and often being the prayer itself. NBC’s Anne Thompson reports for TODAY on how Rome's Pontifical Institute of Sacred Music ...
We recently published a list of 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Pfizer ...
Viking (VKTX) stock, Structure (GPCR) stock and others surge after Pfizer’s obesity drug setback. Read more here.
Shares of Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are on the rise on Monday after Pfizer (PFE) announced its decision to ...
From STAT’s Matthew Herper: Pfizer said this morning that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another medicine with ...
Pokémon’s lovable pocket monsters have been a household favorite for over 30 years, inspiring games and collectibles — including trading cards that now can fetch thousands of dollars. Reporting for ...
Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...
As U.S. President Donald Trump takes aim at the mostly American-owned pharmaceutical factories that dot the Irish countryside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results